Stig Frøland

Q: What Schools Are Affiliated With Stig Frøland

Stig Frøland is affiliated with the following schools: University of Oslo, Norwegian University of Science and Technology

Stig Frøland's AcademicInfluence.com Rankings

Stig Frøland

Philosophy

#6487

World Rank

#9529

Historical Rank

Logic

#7066

World Rank

#8689

Historical Rank

philosophy Degrees

Download Badge

Philosophy

Why Is Stig Frøland Influential?

(Suggest an Edit or Addition)

According to Wikipedia, Stig Sophus Frøland is a Norwegian professor of medicine. He was born in Sør-Odal as a brother of Dag Frøland. He took the dr.med. degree in 1973 and specialist qualification in internal medicine in 1980, later also in infectious diseases in 1983. He has served as chief physician at Rikshospitalet from 1986 and professor at the University of Oslo from 1993 to his retirement.

(See a Problem?)

Stig Frøland's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Enhanced levels of soluble and membrane-bound CD40 ligand in patients with unstable angina. Possible reflection of T lymphocyte and platelet involvement in the pathogenesis of acute coronary syndromes. (1999) (555)
Cytokine network in congestive heart failure secondary to ischemic or idiopathic dilated cardiomyopathy. (1999) (476)
Increased Expression of Visfatin in Macrophages of Human Unstable Carotid and Coronary Atherosclerosis: Possible Role in Inflammation and Plaque Destabilization (2007) (459)
Identification, Enumeration, and Isolation of B and T Lymphocytes from Human Peripheral Blood (1974) (349)
Immunomodulating Therapy With Intravenous Immunoglobulin in Patients With Chronic Heart Failure (2001) (345)
Elevated circulating levels of C-C chemokines in patients with congestive heart failure. (1998) (344)
Hepatitis C infection in patients with primary hypogammaglobulinemia after treatment with contaminated immune globulin. (1994) (311)
Serum Levels of Tumor Necrosis Factor-α (TNFα) and Soluble TNF Receptors in Human Immunodeficiency Virus Type 1 Infection-Correlations to Clinical, Immunologic, and Virologic Parameters (1994) (291)
Subcutaneous immunoglobulin replacement in patients with primary antibody deficiencies: safety and costs (1995) (268)
Increased systemic and myocardial expression of neutrophil gelatinase-associated lipocalin in clinical and experimental heart failure. (2009) (256)
Effect of high- versus low-dose angiotensin converting enzyme inhibition on cytokine levels in chronic heart failure. (1999) (237)
Dysregulated Osteoprotegerin/RANK Ligand/RANK Axis in Clinical and Experimental Heart Failure (2005) (217)
Myocardial expression of CC- and CXC-chemokines and their receptors in human end-stage heart failure. (2000) (207)
Decreased bone formative and enhanced resorptive markers in human immunodeficiency virus infection: indication of normalization of the bone-remodeling process during highly active antiretroviral therapy. (1999) (193)
Release of cytokines, soluble cytokine receptors, and interleukin-1 receptor antagonist after intravenous immunoglobulin administration in vivo. (1994) (192)
Primary Immunodeficiency Diseases in Norway (2000) (182)
Enhanced T-Cell Expression of RANK Ligand in Acute Coronary Syndrome: Possible Role in Plaque Destabilization (2006) (182)
Identification of Three Different Human Lymphocyte Populations by Surface Markers (1973) (177)
Elevated levels of serum-soluble CD14 in human immunodeficiency virus type 1 (HIV-1) infection: correlation to disease progression and clinical events. (1998) (175)
Severe deficiency of 1,25-dihydroxyvitamin D3 in human immunodeficiency virus infection: association with immunological hyperactivity and only minor changes in calcium homeostasis. (1998) (169)
Increased Expression of Interleukin-1 in Coronary Artery Disease With Downregulatory Effects of HMG-CoA Reductase Inhibitors (2004) (167)
Tumor necrosis factor (TNF) system levels in human immunodeficiency virus-infected patients during highly active antiretroviral therapy: persistent TNF activation is associated with virologic and immunologic treatment failure. (1999) (165)
Enhanced activation of platelets with abnormal release of RANTES in human immunodeficiency virus type 1 infection. (1998) (162)
Enhanced expression of inflammatory cytokines and activation markers in T-cells from patients with chronic heart failure. (2003) (157)
Stromal Cell–Derived Factor-1&agr; in Unstable Angina: Potential Antiinflammatory and Matrix-Stabilizing Effects (2002) (153)
Elevated Levels of Activin A in Heart Failure: Potential Role in Myocardial Remodeling (2004) (151)
Persistent activation of the tumor necrosis factor system in a subgroup of patients with common variable immunodeficiency--possible immunologic and clinical consequences. (1996) (151)
Subnormal serum concentration of 1,25-vitamin D in human immunodeficiency virus infection: correlation with degree of immune deficiency and survival. (1994) (149)
Interaction between chemokines and oxidative stress: possible pathogenic role in acute coronary syndromes. (2001) (148)
CXC-chemokines, a new group of cytokines in congestive heart failure--possible role of platelets and monocytes. (2000) (146)
Enhanced Expression of the Homeostatic Chemokines CCL19 and CCL21 in Clinical and Experimental Atherosclerosis: Possible Pathogenic Role in Plaque Destabilization (2007) (141)
Increased serum osteoprotegerin in disorders characterized by persistent immune activation or glucocorticoid excess--possible role in bone homeostasis. (2001) (136)
Raised serum levels of soluble CD40 ligand in patients with familial hypercholesterolemia: downregulatory effect of statin therapy. (2003) (132)
Human Lymphocytes with Receptors for IgG (1974) (131)
Increased levels of oxidized glutathione in CD4+ lymphocytes associated with disturbed intracellular redox balance in human immunodeficiency virus type 1 infection. (1995) (129)
Interleukin-7–Mediated Inflammation in Unstable Angina: Possible Role of Chemokines and Platelets (2003) (127)
Etiology of community-acquired pneumonia and diagnostic yields of microbiological methods: a 3-year prospective study in Norway (2015) (122)
Inflammatory imbalance between IL‐10 and TNFα in unstable angina potential plaque stabilizing effects of IL‐10 (2002) (117)
Soluble CD40 Ligand in Pulmonary Arterial Hypertension: Possible Pathogenic Role of the Interaction Between Platelets and Endothelial Cells (2004) (113)
Hydroxymethylglutaryl coenzyme a reductase inhibitors down-regulate chemokines and chemokine receptors in patients with coronary artery disease. (2003) (112)
Interferons and interferon (IFN)‐inducible protein 10 during highly active anti‐retroviral therapy (HAART)—possible immunosuppressive role of IFN‐α in HIV infection (2000) (112)
Antibody-dependent cytotoxicity mediated by human Fc-receptor-bearing cells lacking markers for B- and T-lymphocytes. (1974) (109)
Enhanced gene expression of chemokines and their corresponding receptors in mononuclear blood cells in chronic heart failure--modulatory effect of intravenous immunoglobulin. (2001) (104)
Same Idiotypc of B‐Lymphocyte Membrane IgD and IgM. Formal Evidence for Monoclonality of Chronic Lymphocytic Leukemia Cells (1974) (104)
Serum levels of tumor necrosis factor-alpha (TNF alpha) and soluble TNF receptors in human immunodeficiency virus type 1 infection--correlations to clinical, immunologic, and virologic parameters. (1994) (103)
Comparison of preference-based utilities of the 15D, EQ-5D and SF-6D in patients with HIV/AIDS (2005) (101)
Antibody-dependent lymphocyte-mediated cytotoxicity in man: no requirement for lymphocytes with membrane-bound immunoglobulin. (1973) (98)
Levels of circulating adhesion molecules in congestive heart failure and after heart transplantation. (1998) (96)
Low numbers of regulatory T cells in common variable immunodeficiency: association with chronic inflammation in vivo (2007) (94)
Increased gene expression of tumor necrosis factor superfamily ligands in peripheral blood mononuclear cells during chronic heart failure. (2002) (93)
Virological and immunological effects of antioxidant treatment in patients with HIV infection (2000) (92)
Myocardial gene expression of leukaemia inhibitory factor, interleukin‐6 and glycoprotein 130 in end‐stage human heart failure (2001) (92)
Disturbed glutathione metabolism and decreased antioxidant levels in human immunodeficiency virus-infected patients during highly active antiretroviral therapy--potential immunomodulatory effects of antioxidants. (2003) (92)
Interleukin-10 enhances the oxidized LDL-induced foam cell formation of macrophages by antiapoptotic mechanisms Published, JLR Papers in Press, November 16, 2004. DOI 10.1194/jlr.M400324-JLR200 (2005) (88)
Decreased levels of total and reduced glutathione in CD4+ lymphocytes in common variable immunodeficiency are associated with activation of the tumor necrosis factor system: possible immunopathogenic role of oxidative stress. (1995) (82)
Effect of pravastatin on plasma markers of inflammation and peripheral endothelial function in male heart transplant recipients. (2001) (79)
International Union of Immunological Societies (IUIS), report-July 1974: Identification, enumeration and isolation of B and T lymphocytes from human peripheral blood (1975) (77)
Effect of Thalidomide on Cardiac Remodeling in Chronic Heart Failure: Results of a Double-Blind, Placebo-Controlled Study (2005) (76)
Soluble CD40 ligand in acute and chronic heart failure. (2005) (76)
Increased activation of protein kinase A type I contributes to the T cell deficiency in common variable immunodeficiency. (1999) (76)
Persistently Elevated Levels of von Willebrand Factor Antigen in HIV Infection (2000) (75)
Increased expression of toll-like receptor 2 on monocytes in HIV infection: possible roles in inflammation and viral replication. (2004) (73)
Sequence analysis of HIV-1 group O from Norwegian patients infected in the 1960s. (1997) (73)
Possible role of interleukin-10 (IL-10) and CD40 ligand expression in the pathogenesis of hypergammaglobulinemia in human immunodeficiency virus infection: modulation of IL-10 and Ig production after intravenous Ig infusion. (1998) (73)
Lifelong treatment with gammaglobulin for primary antibody deficiencies: the patients' experiences of subcutaneous self-infusions and home therapy. (1995) (72)
Impaired Secretion of IL-10 by T Cells from Patients with Common Variable Immunodeficiency–Involvement of Protein Kinase A Type I1 (2003) (72)
Complement Activation in Patients With Congestive Heart Failure: Effect of High-Dose Intravenous Immunoglobulin Treatment (2001) (69)
The role of the tumor necrosis factor system and interleukin-10 during cytomegalovirus infection in renal transplant recipients. (2000) (66)
Effect of metoprolol on cytokine levels in chronic heart failure--a substudy in the Metoprolol Controlled-Release Randomised Intervention Trial in Heart Failure (MERIT-HF). (2001) (65)
Potential anti-inflammatory role of activin A in acute coronary syndromes. (2004) (62)
Coping, quality of life, and hope in adults with primary antibody deficiencies (2005) (62)
A Potential Role of the CXC Chemokine GROα in Atherosclerosis and Plaque Destabilization: Downregulatory Effects of Statins (2008) (60)
Activation of Platelets by Aspergillus fumigatus and Potential Role of Platelets in the Immunopathogenesis of Aspergillosis (2009) (59)
High levels and inflammatory effects of soluble CXC ligand 16 (CXCL16) in coronary artery disease: down-regulatory effects of statins. (2008) (59)
Elevated serum levels of interleukin-4 and interleukin-6 in patients with common variable immunodeficiency (CVI) are associated with chronic immune activation and low numbers of CD4+ lymphocytes. (1994) (58)
Common variable immunodeficiency and the complement system; low mannose‐binding lectin levels are associated with bronchiectasis (2005) (57)
Nonspecific oral immunity in individuals with HIV infection. (1992) (57)
Elevated plasma concentration of reduced homocysteine in patients with human immunodeficiency virus infection. (1996) (55)
Peripheral endothelial dysfunction in heart transplant recipients: possible role of proinflammatory cytokines (2000) (55)
HIV-1 INFECTION IN NORWEGIAN FAMILY BEFORE 1970 (1988) (54)
Risk Factors for Long-Term Mortality after Hospitalization for Community-Acquired Pneumonia: A 5-Year Prospective Follow-Up Study (2016) (54)
Circulating levels of RANTES in human immunodeficiency virus type 1 infection: effect of potent antiretroviral therapy. (1998) (54)
Possible role of proinflammatory cytokines in heart allograft coronary artery disease. (1999) (54)
Evidence that the Mechanism of Immunological Tolerance (‘Central Failure’) Is Operative in the Lack of Host Resistance in Lepromatous Leprosy (1972) (54)
Increased Levels of Soluble CD40L in African Tick Bite Fever: Possible Involvement of TLRs in the Pathogenic Interaction between Rickettsia africae, Endothelial Cells, and Platelets1 (2006) (54)
Enhanced Plasma Levels of LIGHT in Unstable Angina: Possible Pathogenic Role in Foam Cell Formation and Thrombosis (2005) (53)
Abnormal interleukin-7 function in common variable immunodeficiency. (2005) (53)
Development, characterization and use of monoclonal antibodies against sTRAIL: measurement of sTRAIL by ELISA. (2002) (53)
Abnormal levels of circulating adhesion molecules in HIV-1 infection with characteristic alterations in opportunistic infections. (1996) (53)
Effect of thalidomide in patients with chronic heart failure. (2002) (53)
Long-term outcome of chronic hepatitis C virus infection in primary hypogammaglobulinaemia. (1999) (52)
Slowed reaction time in asymptomatic HIV‐positive patients (1992) (52)
Increased levels of neutrophil-activating peptide-2 in acute coronary syndromes: possible role of platelet-mediated vascular inflammation. (2006) (51)
Plasma levels of soluble tumor necrosis factor receptor type I during the acute phase following complicated myocardial infarction predicts survival in high-risk patients. (2005) (50)
Decreased serum lipocalin‐2 levels in human immunodeficiency virus‐infected patients: increase during highly active anti‐retroviral therapy (2008) (49)
Enhanced interleukin-10 production in response to Mycobacterium avium products in mononuclear cells from patients with human immunodeficiency virus infection. (1998) (49)
Intraepithelial gamma/delta T cells in duodenal mucosa are related to the immune state and survival time in AIDS (1996) (47)
Disseminated Mycobacterium avium complex infection in AIDS: immunopathogenic significance of an activated tumor necrosis factor system and depressed serum levels of 1,25 dihydroxyvitamin D. (1996) (47)
Impaired base excision repair and accumulation of oxidative base lesions in CD4+ T cells of HIV-infected patients. (2005) (46)
CXC‐chemokines in coronary artery disease: possible pathogenic role of interactions between oxidized low‐density lipoprotein, platelets and peripheral blood mononuclear cells (2003) (46)
Development of pulmonary abnormalities in patients with common variable immunodeficiency: associations with clinical and immunologic factors. (2010) (45)
Human immunodeficiency virus infection of the brain II. Detection of intrathecally synthesized antibodies by enzyme linked immunosorbent assay and imprint immunofixation (1988) (45)
Low mannose-binding lectin and increased complement activation correlate to allograft vasculopathy, ischaemia, and rejection after human heart transplantation. (2005) (45)
Same idiotype of B-lymphocyte membrane IgD and IgM. Formal evidence for monoclonality of chronic lymphocytic leukemia cells. (1974) (44)
High resolution computed tomography and pulmonary function in common variable immunodeficiency. (2009) (43)
Increased expression of fractalkine (CX3CL1) and its receptor, CX3CR1, in Wegener's granulomatosis--possible role in vascular inflammation. (2007) (43)
Oral candidiasis is associated with low levels of parotid calprotectin in individuals with infection due to human immunodeficiency virus. (1993) (41)
Raised serum levels of interleukin-8 and interleukin-18 in relation to bone metabolism in endogenous Cushing's syndrome. (2002) (41)
Human lymphocytes with receptors for IgG. A population of cells distinct from T- and B-lymphocytes. (1974) (40)
Elevated serum calprotectin levels in HIV-infected patients: the calprotectin response during ZDV treatment is associated with clinical events. (1994) (38)
Mutation pattern in the Bruton's tyrosine kinase gene in 26 unrelated patients with X‐linked agammaglobulinemia (1997) (36)
Mannose binding lectin and soluble Toll-like receptor 2 in heart failure following acute myocardial infarction. (2006) (36)
Mannose-binding lectin in HIV infection: relation to disease progression and highly active antiretroviral therapy. (2003) (36)
Chemokines and soluble adhesion molecules in renal transplant recipients with cytomegalovirus infection (2000) (35)
Immune modulatory effects of cyclooxygenase type 2 inhibitors in HIV patients on combination antiretroviral treatment (2006) (35)
Dysregulation of membrane-bound tumor necrosis factor-alpha and tumor necrosis factor receptors on mononuclear cells in human immunodeficiency virus type 1 infection: low percentage of p75-tumor necrosis factor receptor positive cells in patients with advanced disease and high viral load. (1997) (35)
Expression of matrix metalloproteinases in patients with Wegener’s granulomatosis (2004) (35)
Early and late effects of irradiation for seminoma testis on the number of blood lymphocytes and their B and T subpopulations. (1975) (34)
The role of intravenous immunoglobulin in the treatment of chronic heart failure. (2006) (33)
Prevalence of neuropsychological deficit in HIV infection. Incipient signs of AIDS dementia complex in patients with AIDS (1991) (33)
Reduced serum level of transforming growth factor-beta in patients with IgA deficiency. (1995) (33)
IL-10 Enhances MD-2 and CD14 Expression in Monocytes and the Proteins Are Increased and Correlated in HIV-Infected Patients1 (2009) (33)
Homeostatic chemokines CCL19 and CCL21 promote inflammation in human immunodeficiency virus‐infected patients with ongoing viral replication (2009) (33)
Cytokine networks are pre-activated in T cells from HIV-infected patients on HAART and are under the control of cAMP (2004) (33)
Relative chemokine and adhesion molecule expression in Mediterranean spotted fever and African tick bite fever. (2009) (32)
Complex effects of interferon-alpha on the cytokine network in HIV infection--possible contribution to immunosuppression. (2001) (31)
Chemokines in Children With Heterozygous Familiar Hypercholesterolemia: Selective Upregulation of RANTES (2006) (31)
Inflammatory Interaction Between LIGHT and Proteinase-Activated Receptor-2 in Endothelial Cells: Potential Role in Atherogenesis (2008) (30)
Studies of human peripheral lymph. II. Low lymphocyte count and few B-lymphocytes in peripheral lymph of patients with chronic lymphocytic leukaemia. (2009) (30)
Lipid‐lowering and anti‐inflammatory effects of tetradecylthioacetic acid in HIV‐infected patients on highly active antiretroviral therapy (2004) (30)
Soluble toll-like receptor 2 in HIV infection: association with disease progression (2004) (30)
Polyclonal expansion of large granular lymphocytes in common variable immunodeficiency − association with neutropenia (2006) (30)
Omega-3 fatty acids enhance tumor necrosis factor-alpha levels in heart transplant recipients. (2001) (30)
Increased expression of chemokines in patients with Wegener's granulomatosis − modulating effects of methylprednisolone in vitro (2005) (29)
The insulin-like growth factor system in human immunodeficiency virus infection: relations to immunological parameters, disease progression, and antiretroviral therapy. (2001) (29)
Only temporary improvement in impaired neuropsychological function in AIDS patients treated with zidovudine. (1991) (28)
The spectrum of hepatobiliary disease in primary hypogammaglobulinaemia (1999) (28)
The tumour necrosis factor superfamily ligand APRIL (TNFSF13) is released upon platelet activation and expressed in atherosclerosis (2009) (28)
Chemokines in myocardial failure – pathogenic importance and potential therapeutic targets (2001) (27)
Corynebacterium pseudotuberculosis Pneumonia in a Veterinary Student Infected During Laboratory Work (2015) (27)
Enhanced levels of the CCR7 ligands CCL19 and CCL21 in HIV infection: correlation with viral load, disease progression and response to highly active antiretroviral therapy (2009) (26)
Effect of activated platelets on expression of cytokines in peripheral blood mononuclear cells – potential role of prostaglandin E2 (2004) (26)
Altered IgG-subclass distribution in lymph node cells and serum of adults infected with human immunodeficiency virus (HIV). (1989) (26)
Complement activation during cardiopulmonary bypass: comparison between the use of large volumes of plasma and dextran 70. (1988) (25)
Immunodeficiency syndromes with otorhinolaryngological manifestations. (1976) (25)
Lymphocyte subpopulations in rheumatoid arthritis. (1975) (24)
Common variable immunodeficiency revisited: normal generation of naturally occurring dendritic cells that respond to Toll‐like receptors 7 and 9 (2014) (24)
Immunogenicity of yeast-derived hepatitis B vaccine from two different producers (1990) (24)
Effects of interferon-alpha on gene expression of chemokines and members of the tumour necrosis factor superfamily in HIV-infected patients. (2002) (24)
Increased expression of LIGHT/TNFSF14 and its receptors in experimental and clinical heart failure ☆ (2008) (24)
Immunologic parameters as predictive factors of cytomegalovirus disease in renal allograft recipients. (1999) (23)
Immunomodulating effects of 3‐thia fatty acids in activated peripheral blood mononuclear cells (2003) (23)
Characterization of subpopulations of human lymphoid cells participating in phytohemagglutinin and concanavalin A-induced cytotoxicity. (1974) (23)
Modulatory effect of mannose‐binding lectin on cytokine responses: possible roles in HIV infection (2005) (23)
Additive effects of IL-2 and protein kinase A type I antagonist on function of T cells from HIV-infected patients on HAART. (1999) (23)
CD4+ and CD8+ lymphocytes and HIV RNA in HIV infection: high baseline counts and in particular rapid decrease of CD8+ lymphocytes predict AIDS. (1999) (22)
High-dose intravenous methylprednisolone pulse therapy as initial treatment in cryptogenic fibrosing alveolitis. A pilot study. (1986) (21)
Toll like receptor 5 (TLR5) may be involved in the immunological response to Aspergillus fumigatus in vitro. (2011) (21)
Nonsecretory myelomatosis without intracellular immunoglobulin. Immunofluorescent and ultramicroscopic studies. (2009) (21)
Effects of intravenous immunoglobulin in vivo on abnormally increased tumor necrosis factor-alpha activity in human immunodeficiency virus type 1 infection. (1997) (21)
Markedly disturbed glutathione redox status in CD45RA+CD4+ lymphocytes in human immunodeficiency virus type 1 infection is associated with selective depletion of this lymphocyte subset. (1996) (20)
Vitamin D Status and Long-Term Mortality in Community-Acquired Pneumonia: Secondary Data Analysis from a Prospective Cohort (2016) (20)
Lymphocyte populations and cellular immune reactions in juvenile rheumatoid arthritis. (1975) (20)
HIV infection in Norwegian haemophiliacs: The prevalence of antibodies against HIV in haemophiliacs treated with lyophilized cryoprecipitate from volunteer donors (1987) (20)
Treatment with type-2 selective and non-selective cyclooxygenase inhibitors improves T-cell proliferation in HIV-infected patients on highly active antiretroviral therapy (2004) (20)
Hypertension in relation to nitric oxide, asymmetric dimethylarginine, and inflammation: different patterns in heart transplant recipients and individuals with essential hypertension (2002) (18)
Distribution and phenotypes of duodenal intraepithelial γ/δ T cells in patients with various types of primary B-cell deficiency (1993) (18)
Cytomegalovirus (CMV) pneumonitis in AIDS patients: the result of intensive CMV replication? (1992) (18)
Lymphocyte populations and cellular immune reactions in vitro in patients with multiple sclerosis. (1978) (18)
Reduced immunoglobulin levels in epilepsy patients treated with levetiracetam, lamotrigine, or carbamazepine (2013) (18)
Myocardial gene expression of inflammatory cytokines after heart transplantation in relation to the development of transplant coronary artery disease. (2003) (18)
Classes and Subclasses of Surface-Bound Immunoglobulins on Peripheral Blood Lymphocytes in Man (1971) (17)
Increased levels of biochemical markers of bone turnover in relation to persistent immune activation in common variable immunodeficiency (2001) (17)
Expression of genes in normal human monocytes in response to Aspergillus fumigatus. (2008) (17)
Chemokines and common variable immunodeficiency; possible contribution of the fractalkine system (CX3CL1/CX3CR1) to chronic inflammation. (2009) (16)
A study of the variable heavy chain (VH) region of membrane-bound Ig on human chronic leukemic lymphocytes. (1977) (15)
The impact of exposure group on the progression rate to acquired immunodeficiency syndrome. A comparison between intravenous drug users, homosexual men and heterosexually infected subjects. (1997) (15)
Mutation pattern in the Bruton's tyrosine kinase gene in 26 unrelated patients with X-linked agammaglobulinemia. (1997) (15)
Different effect of 1,25-dihydroxyvitamin D3 on replication of Mycobacterium avium in monocyte-derived macrophages from human immunodeficiency virus-infected subjects and healthy controls. (1998) (15)
Nutritional assessment of anorexia nervosa patients—Analysis of anthropometric and biochemical variables to evaluate patients at risk (1988) (15)
CXCL16 in HIV infection – a link between inflammation and viral replication (2009) (15)
Thalidomide attenuates the development of fibrosis during post‐infarction myocardial remodelling in rats (2006) (15)
Enhanced levels of urokinase plasminogen activator and its soluble receptor in common variable immunodeficiency. (2009) (14)
A follow‐up study of neuropsychological functioning in AIDS‐patients Prognostic significance and effect of zidovudine therapy (1995) (14)
Evidence for complement activation by the alternate pathway in the arthritis of hypogammaglobulinemic patients. (1975) (14)
Enhanced levels of CCL19 in patients with advanced acquired immune deficiency syndrome (AIDS) (2012) (13)
TRANSFER FACTOR IN JUVENILE RHEUMATOID ARTHRITIS (1974) (13)
Activation of tumor necrosis factor — α system in HIV-1 infection: Association with markers of immune activation (2005) (13)
Lung disease, T-cells and inflammation in common variable immunodeficiency disorders (2013) (13)
Ocular polyarteritis nodosa (1987) (12)
Soluble CD 40 Ligand in Pulmonary Arterial Hypertension Possible Pathogenic Role of the Interaction Between Platelets and Endothelial Cells (2004) (12)
Systemic biomarkers of inflammation and haemostasis in patients with chronic necrotizing pulmonary aspergillosis (2012) (11)
Cytomegalovirus Infection Induces Production of Human Interleukin-10 in Macrophages (2003) (11)
Enhanced activation of platelets with abnormal release of RANTES in human immunodeficiency virus type 1 infection (1998) (11)
Two dose regimens of recombinant interferon-alpha-2b in chronic hepatitis C virus infection. Biochemistry, hepatitis C virus RNA, and liver histology as response indices. (1995) (10)
Chemokines and common variable immunodeficiency; possible contribution of CCL19, CCL21 and CCR7 to immune dysregulation (2009) (10)
Increased plasma levels of the terminal complement complex in patients with evidence of complement activation. (1985) (10)
MEASLES-VIRUS-INDUCED MIGRATION INHIBITION OF HUMAN LEUCOCYTES: AN IMMUNOLOGICALLY UNSPECIFIC PHENOMENON? (1975) (10)
HIV-related neuropsychological impairment and immunodeficiency. CD8+ lymphocytes and neopterin are related to HIV-encephalopathy. (1994) (9)
[Risk of infection through use of selective immunomodulating drugs for rheumatoid arthritis]. (2012) (9)
Autopsy findings in three family members with a presumably acquired immunodeficiency syndrome of unknown etiology. (2009) (9)
Liver transplantation for endstage hepatitis C cirrhosis in a patient with primary hypogammaglobulinaemia. (1998) (8)
Lymphocyte subpopulations and immune reactions in rheumatoid inflammatory tissues. (1975) (8)
Cell-mediated immunity in anorexia nervosa augmented lymphocyte transformation response to concanavalin A and lack of increased risk of infection. (1989) (8)
PKAI as a potential target for therapeutic intervention. (2000) (8)
Low Levels of Immunoglobulins and Mannose-Binding Lectin Are Not Associated With Etiology, Severity, or Outcome in Community-Acquired Pneumonia (2018) (8)
The significance of HIV antigen and HIV antibodies specific against envelope and core proteins in serum of HIV‐infected hemophiliacs (1987) (7)
Immunoglobulin-containing intranuclear inclusions in plasma cells in a case of IgG myeloma. (2009) (7)
Immunophenotypic analyses of CD34+ cell subsets in bone marrow from HIV‐infected patients during highly‐ active antiretroviral therapy (2002) (7)
Alterations in lymphocyte subsets in blood may predict resectability in carcinoma of cardia or oesophagus. (1996) (7)
A new principle of immunotherapy in rheumatoid arthritis: treatment with transfer factor. (1974) (6)
[Immunomodulating treatment in advanced heart failure--effect of intravenous immunoglobulin]. (2001) (6)
Bacterial infections in the compromised host. (1984) (6)
Variable heavy chain (VH) subgroups of human autoantibody molecules. Comparison with Ig classes and light chain types. (1978) (6)
Abnormal lymphocyte populations in pure red cell aplasia. (2009) (6)
Duodenal intraepithelial gamma/delta T cells and soluble CD8, neopterin, and beta 2-microglobulin in serum of IgA-deficient subjects with or without IgG subclass deficiency. (1993) (6)
No effect of transfer factor in juvenile rheumatoid arthritis by double-blind trial. (1978) (5)
Distribution and phenotypes of duodenal intraepithelial gamma/delta T cells in patients with various types of primary B-cell deficiency. (1993) (5)
Effect of transfer factor and zoster immunoglobulin in patients with varicella-zoster infection and malignancy. (1978) (5)
Predictive Value of Immunologic Parameters and HIV RNA in Relation to Humoral Pneumococcal Polysaccharide Vaccine Responses in Patients with HIV Infection (2002) (5)
Specificity of receptors for IgG on human cytotoxic plaque-forming mononuclear leukocytes. Induction and inhibition of plaque-forming activity. (1980) (5)
Inhibition of protein kinase A improves effector function of monocytes from HIV-infected patients. (2008) (4)
Monocyte cytotoxicity in connective tissue diseases. Correlation with disease groups. (1981) (4)
Decreased endomyocardial RANKL expression in transplant coronary artery disease. (2006) (4)
The Cellularity of Peripheral Lymph in Lymphomas (1977) (3)
Acquired immunodeficiency syndrome (AIDS). Clinical, immunological, pathological, and microbiological studies of the first case diagnosed in Norway. (1985) (3)
Plaque-forming, antibody-dependent, cytotoxic cells with monocytic properties are present in rheumatoid synovial tissue. (1981) (3)
Transient B cell immaturity with intractable diarrhoea: A possible new immunodeficiency syndrome (1978) (3)
Characterization of an antibody to factor VIII in a patient with acquired hemophilia with circulating immune complexes. (2009) (3)
[Risk of AIDS in the Oslo HIV-cohort study. A comparison between homosexual men, intravenous addicts and heterosexual persons]. (1994) (3)
Identification and functional characterization of monocytes in rheumatoid synovial fluid. (1981) (3)
C-reactive protein and delayed hypersensitivity in juvenile rheumatoid arthritis. (1978) (3)
Lymphocytes from synovial tissue of a boy with X-linked hypogammaglobulinemia and chronic polyarthritis. (1979) (2)
Effect of fibroblast interferon and recombinant gamma interferon on zymosan-induced nitroblue tetrazolium reduction in mouse peritoneal macrophages. (2009) (2)
Alterations in serum cortisol, CD4+ CD8+ lymphocyte sub-population ration and T cell mediated suppression of immune responses in the malnutrition of anorexia nervosa. (1991) (2)
[Churg-Strauss syndrome after treatment with Singulair (montelukast)]. (2002) (2)
The thiols glutathione, cysteine, and homocysteine in human immunodeficiency virus (HIV) infection (2017) (2)
Effect of immunomodulating therapy with intravenous immunglobulin in chronic heart failure (2000) (2)
[Cytomegalovirus disease in the gastrointestinal tract]. (1991) (2)
Selective defects of in vitro parameters of lymphoid cell function in patients with irradiated testicular tumour and in patients with lymphoproliferative disorders. (2009) (2)
Short-chain fatty acids and other intestinal microflora-associated characteristics in faeces of patients with severe B-cell immunodeficiency. (1989) (2)
Intestinal intraepithelial gamma/delta T cells in B-cell deficiency. (1993) (2)
[When force is necessary]. (2014) (2)
[Should patients with severe sepsis be treated with activated protein C?]. (2004) (2)
[Hepatitis C virus infections among persons attending special clinics dealing with problems related to social conditions]. (1993) (2)
Serological markers of hepatitis B virus and cytomegalovirus infections in Norwegians with coagulation factor defects (1990) (2)
Osteoprotegrin and soluble tumor necrosis factor receptor 1 are associated with microalbuminuria in nontreated HIV-infected patients. (2010) (1)
Effects of alpha- and beta-interferon on oxidative burst responses of monocytes and monocyte-derived macrophages from patients with HIV infection. (1990) (1)
Different lymphocyte populations in rheumatoid arthritis and their relationship to anti-Ig activities. (1975) (1)
Soluble CD40 ligand in pulmonary arterial hypertension - possible pathogenic role of interaction between platelets and endothelial cells (2004) (1)
Jacob B. Natvig (1934‐2021), one of the founders of Scandinavian Journal of Immunology (2021) (1)
W13-P-007 Chemokines in children with heterozygous familiar hypercholesterolemia — Selective up-regulation of RANTES (2005) (1)
TT virus infection in patients with primary hypogammaglobulinaemia: natural history and relationship to liver disease in the immunocompromised host. (2001) (1)
Antimicrobial chemoprophylaxis in immunocompromised patients. (1990) (1)
Infections with Pseudomonas aeruginosa in the compromised host. (1981) (1)
[Bone marrow transplantation. Indications in adult patients with leukemia or aplastic anemia]. (1984) (0)
[Antiretroviral treatment of HIV infections in 2001]. (2001) (0)
[Crohn disease or non-Hodgkin's malignant T cell lymphoma? A diagnostic problem evaluated by gene technology DNA analysis]. (1988) (0)
Contents, Vol. 50, 1986 (1986) (0)
[Gene therapy in HIV infection and other viral infections]. (2001) (0)
ncreased Levels of Neutrophil-Activating eptide-2 in Acute Coronary Syndromes (2006) (0)
[25 years of the AIDS epidemic]. (2006) (0)
[Preventive measures against HTLV-III/LAV infections among hemophiliacs and their relatives]. (1986) (0)
[Quantification of T-lymphocyte subpopulations. Immunological marker in human immunodeficiency virus infections]. (1991) (0)
[Protein-calorie malnutrition. Diagnosis and preoperative parenteral nutrition of patients at risk]. (1986) (0)
in vivo receptor antagonist after intravenous immunoglobulin administration Release of cytokines, soluble cytokine receptors, and interleukin-1 (2011) (0)
[Vaccination against hepatitis B virus - soon a reality also in Norway]. (1983) (0)
Studies on Fc-receptor-bearing mononuclear leukocytes from peripheral blood of patients with dermatitis herpetiformis. (1979) (0)
This information is current as Plateletsafricae, Endothelial Cells, and TLRs in the Pathogenic Interaction between Tick Bite Fever: Possible Involvement of Increased Levels of Soluble CD40L in African (2013) (0)
Subject Index, Vol. 50, 1986 (1986) (0)
[2 populations of lymphocytes with different immunological function]. (1971) (0)
[HIV, nutrition and immune defence]. (1993) (0)
Legionella pneumonia--a neglected diagnosis? (1984) (0)
[Symptomatic cytomegalovirus infection in patients with acquired immunodeficiency syndrome]. (1991) (0)
[Silent HIV infection in HIV seronegative persons]. (1990) (0)
[A throat infection with rapid deterioration]. (2002) (0)
Immunomodulatory Treatments with Intravenous Immunoglobulin (2008) (0)
[New immunopathogenetic aspects of infectious diseases]. (1995) (0)
[Toxic shock syndrome without any relation to the use of tampons or staphylococcal infection]. (1989) (0)
Composition for treatment of heart failure (2001) (0)
Professor emeritus Jacob B. Natvig, one of the founders of Scandinavian Journal of immunology, turns 75 (2009) (0)
[Immunosuppressive therapy in hematological diseases. Principles and mechanism of action]. (1983) (0)
Utvikling av Churg-Strauss’ syndrom etter bruk av Singulair (montelukast) (2002) (0)
Interaction of microbial agents with the immune system during infectious disease. (1984) (0)
[Immunofluorescence test in the diagnosis of AIDS-associated virus infection in Norway]. (1986) (0)
[Cellular immunology]. (1971) (0)
Correlated in HIV-Infected Patients in Monocytes and the Proteins Are Increased IL-10 Enhances MD2 and CD 14 Expression (2008) (0)
Anti-Inflammatory Role f Activin A in Acute Coronary Syndromes (2016) (0)
Lymphocyte Populations and Subpopulations in Rheumatoid Arthritis (1981) (0)
[Medical treatment of fulminating attacks of ulcerative colitis]. (1982) (0)
[Common variable immunodeficiency]. (2006) (0)
[Immunodeficiency--a cause of recurrent airway infections in adults]. (1974) (0)
Potential role in the immunopathogenesis of aspergillosis (2009) (0)
Fecal transplantation and the microbiome. (2019) (0)
Letter: Transfer factor in juvenile rheumatoid arthritis. (1974) (0)
Rickettsia TLRs in the Pathogenic Interaction between Tick Bite Fever: Possible Involvement of Increased Levels of Soluble CD40L in African (2006) (0)
[20 years with AIDS in Norway]. (2003) (0)
and Correlated in HIV-Infected Patients in Monocytes and the Proteins Are Increased IL-10 Enhances MD-2 and CD14 Expression (2008) (0)
[Idiopathic midline destructive disease]. (1988) (0)
[Identification and characterization of a 3rd population of human lymphocytes with receptors for IgG (Fc-receptors)]. (1975) (0)
Events Type 1 (HIV-1) Infection: Correlation to Disease Progression and Clinical Elevated Levels of Serum-Soluble CD14 in Human Immunodeficiency Virus (2013) (0)
[Viral hepatitis. New clinical aspects]. (1986) (0)
ENHANCED EXPRESSION OF THE CHEMOKINE CXCL1 IN ATHEROSCLEROTIC DISORDERS, DOWN-REGULATORY EFFECTS OF STATIN (2008) (0)
immunodeficiency--possible immunologic and clinical consequences subgroup of patients with common variable Persistent activation of the tumor necrosis factor system in a (2011) (0)
[Immunological classification of lymphoproliferative conditions]. (1974) (0)
Unusual nuclear inclusions in CNS macrophages of a man with encephalomyelitis and acquired immunodeficiency. (1988) (0)
[Gene therapy in primary immunologic failure]. (2001) (0)
Thiols to Treat AIDS (2000) (0)
Coronary Artery Disease and Atherosclerosis Hydroxymethylglutaryl Coenzyme A Reductase Inhibitors DownRegulate Chemokines and Chemokine Receptors in Patients With Coronary Artery Disease (2016) (0)
[Parasite versus immune system - a fight with uncertain outcome]. (1983) (0)
[Job's syndrome]. (1982) (0)
[Prevention of hepatitis B by vaccination]. (1984) (0)
[Microembolization with granulocyte aggregates caused by complement activation. An important pathogenetic mechanism in bacterial septicemia and shock?]. (1983) (0)
[Hemolytic anemia caused by Mycoplasma pneumoniae infection]. (1979) (0)
[Etiology of chronic pancreatitis]. (1988) (0)
Poor Performance of Bioinformatics Programs for Genotypic Prediction of Coreceptor Usage of HIV-1 Group O Isolates (2010) (0)
[The HIV-epidemics--many unsolved problems, but also some progress]. (1991) (0)
[The patient with impaired defense against infections. Types of defect and spectrum of infectious diseases]. (1983) (0)
Coronary Artery Disease and Atherosclerosis Hydroxymethylglutaryl Coenzyme A Reductase Inhibitors Down-Regulate Chemokines and Chemokine Receptors in Patients With Coronary Artery Disease (2003) (0)
661 Innate immunity in heart failure following acute myocardial infarction (2005) (0)
Antibiotic-associated colitis. (1983) (0)
Surface-bound immunoglobulin on B-lymphocytes, evidence for allelic exclusion. (1974) (0)
Jacob Birger Natvig (2021) (0)
[Primary immunological deficiency diseases. Classification, immunological diagnosis and treatment]. (1971) (0)
[Immunological disease mechanisms in acute and chronic infections]. (1983) (0)

This paper list is powered by the following services:

Other Resources About Stig Frøland

en.wikipedia.org

What Schools Are Affiliated With Stig Frøland?

Stig Frøland is affiliated with the following schools: